CD19 and hematologic disorder: Despite the main mechanism of action, both drugs seem to affect the humoral and cellular responses [50,51], eventually converging on the effect on CD19+ lymphocytes in predicting the response to anti-SARS-CoV-2 vaccination, as it has been observed in patients with hematological malignancies [52].